Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria. by Baulac, S et al.
Stéphanie Baulac, PhD
Guy M. Lenk, PhD*
Béatrice Dufresnois*
Bouchra Ouled Amar
Bencheikh, PhD
Philippe Couarch
Julie Renard
Peter A. Larson
Cole J. Ferguson, MD,
PhD
Eric Noé
Karine Poirier, PhD
Christine Hubans, PhD
Stéphanie Ferreira, PhD
Renzo Guerrini, MD
Reda Ouazzani, MD
Khalid Hamid
El Hachimi, PhD
Miriam H. Meisler, PhD
Eric Leguern, MD, PhD
Correspondence to
Prof. Leguern:
eric.leguern@psl.aphp.fr
Supplemental data
at Neurology.org
Role of the phosphoinositide phosphatase
FIG4 gene in familial epilepsy with
polymicrogyria
ABSTRACT
Objective: The aim of this study was to identify the causal gene in a consanguineous Moroccan
family with temporo-occipital polymicrogyria, psychiatric manifestations, and epilepsy, previously
mapped to the 6q16–q22 region.
Methods:We used exome sequencing and analyzed candidate variants in the 6q16–q22 locus, as well
as a rescue assay in Fig4-null mouse fibroblasts and immunohistochemistry of Fig4-null mouse brains.
Results: A homozygous missense mutation (p.Asp783Val) in the phosphoinositide phosphatase gene
FIG4 was identified. Pathogenicity of the variant was supported by impaired rescue of the enlarged
vacuoles in transfected fibroblasts from Fig4-deficient mice. Histologic examination of Fig4-null
mouse brain revealed neurodevelopmental impairment in the hippocampus, cortex, and cerebellum
as well as impaired cerebellar gyration/foliation reminiscent of human cortical malformations.
Conclusions: This study extends the spectrum of phenotypes associated with FIG4 mutations to
include cortical malformation associated with seizures and psychiatric manifestations, in addition to
the previously described Charcot-Marie-Tooth disease type 4J and Yunis-Varón syndrome.Neurology®
2014;82:1068–1075
GLOSSARY
cDNA 5 complementary DNA; chr6 5 chromosome 6; CMT4J 5 Charcot-Marie-Tooth disease type 4J; GFP 5 green fluorescent
protein; plt 5 pale tremor;WT 5 wild-type; YVS 5 Yunis-Varón syndrome.
Polymicrogyria is a malformation of the cerebral cortex characterized by abnormal lamination and
folding. As a result, the deeper cortical layers develop abnormally and an excessive number of small
gyri form within the cortex.1 Polymicrogyria belongs to the group of cortical malformations secondary
to postmigrational development.1 Clinical manifestations depend on the extent and location of the
polymicrogyric cortex and range from asymptomatic to a severe phenotype variably including intrac-
table epilepsy, cognitive impairment, and neurologic deficits.1 Causes of polymicrogyria are hetero-
geneous and include acquired and genetic etiology. Several genes have been identified for autosomal
recessive forms of polymicrogyria: GPR56 2 in bilateral frontoparietal polymicrogyria; KBP 3 in poly-
microgyria withmicrocephaly; and the RABGTPase genes including RAB3GAP1,4 RAB3GAP2,5 and
RAB186 inWarburgMicro syndrome characterized by bilateral frontal polymicrogyria and thinning of
the corpus callosum. Dominant mutations in TUBA1A,7 TUBB2B,8 and TUBB39 have been asso-
ciated with frontoparietal or diffuse polymicrogyria, in TUBA810 with diffuse polymicrogyria with
agenesis of corpus callosum and optic nerve hypoplasia, in COL18A111 with the Knobloch syndrome,
and in SRPX212 with perisylvian polymicrogyria with rolandic seizures and speech dyspraxia.
We previously reported a consanguineous Moroccan family with segregation of an autosomal
recessive phenotype associating polymicrogyria, epilepsy, and psychiatric manifestations with linkage
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on chromosome 6q16–q22.13 In this study, we
performed whole-exome sequencing and identi-
fied a variant at the homozygous state in FIG4, a
gene that was previously implicated in Charcot-
Marie-Tooth disease type 4J (CMT4J)14 and in
Yunis-Varón syndrome (YVS).15 The causality of
this mutation was reinforced by a functional
assay and the study of cortical development in
Fig4-deficient mice.
METHODS Standard protocol approvals, registrations,
and patient consents. Nine family members (3 affected and 6
unaffected) gave written consent to participate in the study in
accordance with the local committee of the University Mo-
hammed V-Souissi, Rabat, Morocco (no. 108).
Whole-exome sequencing. Exons from 3mg of genomic DNA of
patient V.11 were captured using the SureSelect kit following the
manufacturer’s protocols (Agilent, Santa Clara, CA). The whole-
exome DNA library was sequenced on the HiSeq2000 Illumina
Genome Analyzer (Illumina, San Diego, CA). Sequence reads were
mapped to the reference human genome using whole genomic
sequence, refgene.txt file, and reflink.txt (UCSC hg19) using the
BWA v0.5.9 algorithm (http://samtools.sourceforge.net). A mean
depth of 403 covered the candidate homozygosity region on
chromosome 6 (chr6: 103015795–117950828) for all exons. Only
one gene of the region, LOC285758 (114189178–114194512), was
not covered, and was probably absent from the design in the
SureSelect protocol. Variant detection was performed with the
SAMTools v0.1.17 software (http://samtools.sourceforge.net) and
filtered by different scripts (Perl) to fit quality threshold: depth
$103 and a percentage of reads between 40% and 60%.
Variants were annotated according to snp132.txt.
Validation of exome variants and screening of a patient
cohort by Sanger sequencing. Analysis of exome sequencing
focused on the 6q16–q22 locus (chr6: 103,015,795–117,950,828;
hg19), the unique region with positive logarithm of odds scores.
Variants found by exome sequencing were validated, and segregation
analysis was performed by Sanger sequencing using the Big-Dye
Terminator kit on an ABI Prism 3730 DNA Analyzer (Applied
Biosystems, Foster City, CA). Mutation interpretation was assessed
with Alamut software (Interactive Biosoftware, Rouen, France). The
effect of amino acid substitution on protein function was predicted
using SIFT, PolyPhen-2, and MutationTaster. All 23 exons and
intron-exon junctions of FIG4 (RefSeqNM_014845.5) were
sequenced in 33 additional unrelated patients with polymicrogyria.
Phenotype rescue assay. The p.Asp783Val mutation was incorpo-
rated into the mouse Fig4 complementary DNA (cDNA) clone by
site-directed mutagenesis and the construct was completely sequenced.
Mouse fibroblasts were isolated fromP0mouse tail biopsy by digestion
with collagenase type 2 (Worthington Biochemical, Lakewood, NJ)
and cultured in RPMI 1640 supplemented with 15% fetal bovine
serum and containing penicillin, streptomycin, and amphotericin.
Experiments were performed at passage 3 to 5.16 Fibroblasts at 50%
confluence were cotransfected with Fig4 cDNA and green fluorescent
protein (GFP) cDNA. GFP-positive cells were imaged 18 hours after
transfection with an inverted Leica DM IRB microscope (Leica
Microsystems, Buffalo Grove, IL) equipped with epifluorescence
and an Olympus DP30 BW digital camera (Olympus, Center
Valley, PA). Rescued cells were defined as GFP-positive cells with
fewer than 6 vacuoles. The cell area occupied by vacuoles was
quantitated using ImageJ software.
Caspase 3/7 activity assay. Ten percent brain homogenates
were prepared, and cleavage of aminoluciferin-tagged DEVD
peptide was measured. After centrifugation of homogenates at
15,000g, protein concentration in the supernatant was adjusted
to 0.02 mg/mL. An equal volume of homogenate and Caspase-
Glo 3/7 reagent (Promega, Madison, WI) was added to a white-
walled 96-well plate and incubated at room temperature for
60 minutes. Luminescence was read on a Promega GloMax-
Multiplate luminometer.
Western blot. Whole mouse brains were removed and lysed in 5 M
urea, 2.5% sodiumdodecyl sulfate, 50mMTris, 30mMNaCl buffer.
Protein concentration was determined by the Bradford method.
Twenty-five micrograms of each sample was separated on 10% Tris-
glycine polyacrylamide gels and analyzed by Western blot using
monoclonal anti-FIG4 antibody (NeuroMab clone N202/7) and
rabbit polyclonal anti-actin antibody (Sigma-Aldrich, St. Louis, MO).
Histochemistry. Brains from mice aged P0 and P4 (n5 5 for each
genotype) were removed and postfixed for 24 hours in 4% parafor-
maldehyde in 0.1 mol/L phosphate buffer, pH 7.4. Seven-
micrometer-thick paraffin sections were cut. Immunohistochemistry
was performed using rabbit Calbindin D-28k (Swant, Marly,
Switzerland) and Nissl counterstaining using standard procedures.
Morphometry. A drawing of the cerebellar fissures of midsagittal sec-
tions at 403 was made as previously reported17 using a Leica SCN
slide scanner. We measured 6 principal fissures (precentral, preculmi-
nate, primary, prepyramidal, secondary, and posterolateral) by the
Image Processing Toolbox of CaloPix software viewer (http://www.
teleslide.fr). Measurements of fissures are given as mean (6 standard
error) and compared using a Mann-Whitney test.
RESULTS Clinical characterization. Clinical data of the
Moroccan kindred with 6 affected siblings were previ-
ously reported.13 Since our previous publication, V.8
died of a seizure and V.9 committed suicide. In this
family, 6 patients had epilepsy (complex focal and sec-
ondarily generalized seizures). Seizures consisted of visual
hallucinations, sometimes followed by auditory halluci-
nations, as well as epigastric and thoracic oppression or
neurovegetative symptoms suggesting that the epileptic
discharges spread to the temporal lobe. The course and
severity of epilepsy were variable from one patient to
another for age at onset, ranging from birth (V.5 and
V.11) to 24 years (V.1), and frequency of seizures rang-
ing from 1 to 2 per month (V.1) to several per day (V.8
and V.9). The outcome of epilepsy largely depended on
the compliance of patients with their antiepileptic med-
ication; sudden death (SUDEP) occurred in 2 patients,
V.5 and V.6, who were untreated. In addition, severe
psychiatric manifestations were reported in 4 patients
(V.1, V.8, V.9, and V.11). A psychotic disorder with
aggressiveness and delirium was diagnosed in patients
V.8 and V.11. Patient V.1 manifested chronic
aggressiveness toward relatives. In addition, 2 patients
(V.1, V.9) committed suicide.
The 3 patients examined by brain MRI, V.8, V.9,
and V.11, exhibited a thickened irregular cortex in the
lateral occipital lobes with small gyri and were diagnosed
with bilateral occipital polymicrogyria.13 Upon critical
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re-evaluation of MRI in these 3 patients by the neurol-
ogist participating in this study (R.G.), we concluded
that the cortical abnormality also involved the lateral part
of the posterior temporal lobes. Patients therefore had
temporo-occipital rather than occipital polymicrogyria
(figure 1). Family members IV.1 (the father) and V.7
(a nonaffected sibling) had normal brain MRI.
Molecular studies. We previously mapped the causative
gene to a unique 14-Mb locus on chromosome 6q16–
q22.13 Here, we performed whole-exome sequencing in
one patient (V.11),13 and focused our analysis on the
6q16–q22 region (chr6: 103,015,795–117,950,828;
hg19). This rare phenotype segregated as an autosomal
recessive disorder in the consanguineous pedigree.
Therefore, we filtered nonsynonymous and insertion/
deletion variants located in this interval in the
homozygous state with frequency ,1% in the
databases (dbSNP135, 1000 Genomes Project
database, and National Heart, Lung, and Blood
Institute exome variant server database). Only 2
missense variants were identified: c.716T.G/
p.Leu239Arg in TUBE1 that was previously excluded
because of its high frequency in aMaghrebian cohort of
controls (2% allele frequency)13 and c.2348A.T/
p.Asp783Val located in exon 20 of the FIG4 gene.
Both parents were heterozygous for the variant in
FIG4, which fully cosegregated with the phenotype
in the family (figure 2A). This variant was absent
from the dbSNP135, 1000 Genomes Project, and
exome variant server databases. Additionally, it was
not found in 750 in-house controls, including 422
ethnically matched from Maghreb. At the protein
level, the Asp783 residue is located in the C-
terminus of the protein (figure 2B) and is invariant
in mammals and terrestrial vertebrates (figure 2C). Asp
and Val have a high Grantham distance of 152 (0–215)
reflecting the chemical dissimilarity between the
negatively charged, polar aspartate residue and the
hydrophobic valine residue. The prediction software
tools MutationTaster, PolyPhen-2, and SIFT
predicted that this variant was pathogenic,
possibly damaging, and tolerated, respectively.
Sanger sequencing of the complete coding region of
FIG4 did not reveal pathogenic mutations in 33
additional patients with various types of polymicrogyria.
Functional studies in Fig4-null fibroblasts. FIG4 encodes a
phosphoinositide 5-phosphatase that regulates the
cellular abundance of the signaling lipid PI(3,5)P2,
and thus endosomal trafficking and autophagy.
Complete loss of Fig4 in the null mouse mutant pale
tremor (plt) results in extensive neurodegeneration of
the central and peripheral nervous system.14,18 The
cytoplasm of cultured fibroblasts from plt mice is
filled with enlarged vacuoles.14,18 To assess the
functional effect of the p.Asp783Val (D783V) variant,
we performed a phenotype rescue of vacuolization in
cultured cells. Transfection of Fig4-null cells with wild-
type (WT) Fig4 cDNA rescues the vacuoles, while the
Fig4-D783V is defective in rescue (figure 2D). In the
combined data from 3 independent experiments
represented in figure 2E, the WT cDNA completely
corrected vacuolization in 60% of transfected cells
(334/558) while the D783V cDNA corrected
vacuolization in only 33% of transfected cells (262/
797) (p , 0.01, t test). In cells that were not
completely corrected by the mutant cDNA, the total
area occupied by vacuoles was significantly reduced by
expression of the D783V cDNA (p , 0.001, Yates
correction x2) (figure 2F). These data demonstrate
that the D783V mutation causes partial but not
complete loss of FIG4 function.
Histologic studies in Fig4-null brains.To further investigate
the role of Fig4 in cortical development, we examined
Figure 1 Brain MRI
(A, B) Patient V.8, (C, D) patient V.9, and (E, F) patient V.11. Images A and E are T1-weighted
sagittal sections; B, D, and F are T2-weighted axial sections; and C is a T2-weighted coronal
section. The areas of abnormal cortical development in the temporo-occipital areas are indi-
cated by the white arrows and are consistent in all 3 patients with a combination of
increased cortical thickness, smooth cortex, overfolding, and microgyri.
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Figure 2 Identification of FIG4 mutation
(A) Pedigree of the familywith segregation of the FIG4 variant. Only generations IV andV are shown.13 (B) FIG4 is amultidomain protein with a protein interaction
domain at the N-terminus, a SAC phosphatase domain in the central region, and poly-Pro and poly-Ser domains within the C-terminal. The mutation identified in
this study is indicated in red, and missense mutations previously reported in Charcot-Marie-Tooth disease type 4J21 and Yunis-Varón syndrome15 are indicated
in black and blue, respectively. (C) Multiple protein alignment showing conservation of the aspartate (D) residue in position 783 in orthologs of FIG4 across
species. (D) Phenotype rescue in Fig4-null fibroblasts of plt mice. Mutant or wild-type (WT) Fig4 cDNA was cotransfected with GFP into Fig4-null fibroblasts.
The large intracytoplasmic vesicles characteristic of Fig4-null fibroblasts were rescued in 60% of cells by theWT cDNA (top panels) but in only 33% of cells by
the D783Vmutant cDNA (bottom panels). (E) Percent of transfected (GFP-positive) fibroblasts that lack vacuoles. The results of 3 independent experiments are
indicated. *p , 0.01. (F) The D783V mutant retains partial activity. In nonrescued cells from panel E, the percentage of cell area covered by vacuoles in cells
expressing D783V (3.3% 6 0.6%, n 5 24) is smaller than that in cells receiving vector only (10.3%6 1.8%, n 5 22) (2-tailed p value ,0.001). Transfection
of the mutant cDNA does not completely rescue the formation of vacuoles but does reduce the severity of vacuolization. cDNA 5 complementary DNA;
GFP 5 green fluorescent protein; plt 5 pale tremor.
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the temporal expression of the protein in developing
mouse brain by Western blot of whole-brain lysates
between embryonic day 10.5 (E10.5) and postnatal
day P14, before spongiform degeneration. FIG4
protein expression could be detected as early as E10.5,
consistent with a neurodevelopmental role (figure e-1 on
the Neurology® Web site at Neurology.org). We then
asked whether neurodevelopmental defects of the brain
were present in plt mice, as in patients with
polymicrogyria. No obvious macroscopic modification
was observed in brains of plt mice at postnatal age P0
and P4 (data not shown). However, histologic Nissl
staining revealed increased neuronal density in plt
mice in all cortical layers at P0 (figures 3A and e-2),
which was no longer present at P4 (figure 3A), likely due
to cell death. Indeed, during this time interval, the level
of the apoptosis-associated activated caspase 3/7 was
transiently elevated in the mutant brain (figure 3B).
Because expression of calbindin D-28k is correlated
with postnatal maturation of hippocampal dentate
granule cells19 and dendritic arborization,20 we
performed anti-calbindin immunohistochemistry
of the WT and plt brains (n 5 5 for each).
Calbindin staining was drastically decreased in plt
mice, indicating delayed maturation of interneurons
and dentate granule cells and their processes in the
hippocampus at P4 (figure 3C), in the soma and
dendritic tree of Purkinje cells at P0 (figure e-3A) and
P4 (figure 3D), and in cortical interneurons of plt mice
(figure e-3B). Morphometric study of postnatal cerebellar
development at P4 revealed a significant reduction in the
depth of all fissures in plt mice, with the exception of
the primary fissure, demonstrating delayed cerebellar
gyration/foliation (Mann-Whitney test, p , 0.05)
(figures 3E and e-4). These findings support
both impaired molecular development (decreased
calbindin expression) and impaired anatomical
development (gyration) in Fig4-deficient mice,
reflecting postmigration abnormalities that are
considered to be the major mechanisms underlying
polymicrogyria in human.1
DISCUSSION The present study extends to poly-
microgyria the spectrum of phenotypes associated with
FIG4 mutations, which were previously identified in
CMT4J14,21 and YVS15 (figure 2B). A key question is
how FIG4mutations can lead to such diverse autosomal
recessive disorders: (1) CMT4J, a peripheral neuropa-
thy, (2) YVS, in which neurodegeneration and brain
malformations are associated with cleidocranial dyspla-
sia, digital anomalies, and early death, and (3) temporo-
occipital polymicrogyria with seizures and psychiatric
features. The major distinction is that patients with
YVS are homozygous or compound heterozygous
for null mutations of FIG4, and thus exhibit
complete loss of function, similar to the plt
mouse. In contrast, patients with CMT4J and
polymicrogyria retain partial function of FIG4.
Consistent with this view, the missense mutations
found in patients with YVS (figure 2B) exhibit
complete loss of function in the rescue of
vacuolization by Fig4-null fibroblasts,15 while
partial function is demonstrated for the missense
mutations p.Ile41Thr16 and p.Asp783Val (this
study). Spongiform neurodegeneration is only
seen with complete loss of FIG4 function in the
plt mouse and patients with YVS. Patients with
CMT4J are compound heterozygotes carrying a
null allele in combination with the partial loss-of-
function allele p.Ile41Thr mutation14,21 (figure 2B).
The p.Ile41Thr mutation impairs protein stability and
interaction with the scaffold protein VAC14, but
overexpression of the mutant protein can rescue
lethality of the plt mouse, demonstrating residual
function.16 Based on their location in different protein
domains, the p.Asp783Val mutation causing
polymicrogyria might impair interaction with a different
set of proteins than p.Ile41Thr, thereby resulting in
cortical malformation rather than peripheral
neuropathy. There is some phenotypic overlap between
the disorders caused by FIG4mutations, because patients
with YVS exhibit brain malformations including
underdeveloped gyri and polymicrogyria that are
the hallmark of the phenotype associated with the
p.Asp783Val mutation.22,23 Interestingly, Walch et al.22
noted that in one patient with YVS, the areas of neuronal
vacuolization did not overlap with areas exhibiting
pachygyria and polymicrogyria, indicating that the
process of neurodegeneration might mask preceding
cortical abnormalities. Two features present in the
family we are describing could also modulate
conclusions on phenotype-genotype correlations: (1) we
noted enlarged cerebral ventricles atMRI in patients V.8,
V.9, and V.11,13 a feature also seen in Fig4-null mice,14
which might reflect a neurodegenerative process much
milder than that occurring in YVS; and (2) an axonal
sensory and motor neuropathy was diagnosed in patient
V.9 that is related to the peripheral neuropathy occurring
in CMT4J.13 However, in patients with CMT4J, the
pathologic process is also demyelinating and
associated with an age at onset that is variable,
sometimes occurring in childhood. Because other
patients of the family did not exhibit signs of
neuropathy at age 23 (V.11), 35 (V.8), or 55 (V.1)
years, it is uncertain whether the neuropathy
diagnosed in patient V.9 is related to the FIG4
mutation. In addition, the electrophysiologic
examination of V.8 was fully normal.
Polymicrogyria is a common cortical malforma-
tion and is associated with different morphologic pat-
terns and syndromes. Its pathogenesis is not fully
understood; brain pathology demonstrates abnormal
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Figure 3 Neurodevelopmental anomalies in plt mice
(A) Nissl staining of cortex from plt homozygote and WT littermate at postnatal days P0 and P4. Note presence of swollen neurons in layers IV and V of plt
aged P4. Cortical layers are indicated as follows: I–VI, WM (white matter), CC (corpus callosum). (B) Caspase 3/7 activity wasmeasured in brain homogenates
from 3 animals of each genotype at the indicated postnatal age. An unpaired Student t test was used to generate p values at each age. (C) Weak calbindin
immunoreactivity in hippocampus of plt mouse compared with WT littermates. Higher magnification of dorsal DG (boxed regions) shows many granule cells
with a well-developed dendrite tree in theWT brain, while in the plt, there is weak staining of the perikaryon and no immunostaining of dendrite trees. (D) Very
weak calbindin immunoreactivity in cerebellar cortex and deep nucleus (arrows) in pltmouse compared withWT littermate at P4. Boxed areas are focused on
posterolateral fissures. Scale bars: A, 100 mm; C, 300 mm (boxed area 50 mm); D, 250 mm (boxed area 50 mm). (E) Histogram representing the fissure lengths
in the cerebellum at P4 (n5 5). Significant differences between lengths of fissures were observed betweenWT and plt. *p, 0.05; **p, 0.01. DG5 dentate
gyrus; n.s. 5 not significant; plt 5 pale tremor; WT 5 wild-type.
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development or loss of neurons in middle and deep
cortical layers, variably associated with an unlayered
cortical structure.24 Clinical, pathologic, and imaging
heterogeneity suggest that polymicrogyria is not a sin-
gle malformation. Different types of single gene inher-
itance have been reported, and causative mutations
have been identified in several genes such as GPR56,2
KBP,3 NHEJ1,25 TUBB2B,8 TUBB3,9 TUBA8,10 and
TUBA1A7 as well as RAB3GAP1,4 RAB3GA2,5 and
RAB186 encoding Ras-related small GTPases that reg-
ulate membrane trafficking in organelles and transport
of endolysosomal vesicles. The function of FIG4 is
related to the Ras GTPases because it is involved in
the control of intracellular PI(3,5)P2 concentration.
The coordinated regulation of specific RABs and phos-
phoinositides is emerging as an important mechanism
to ensure precision and fidelity of membrane traffick-
ing,26 which seems to be crucial for postmigrational
development of neurons.
Our findings implicate FIG4 in the pathogenesis
of a temporo-occipital polymicrogyria associated with
epilepsy and psychiatric manifestations. It is hoped
that this discovery will shed light on the complex
biology underlying the formation of cortical gyri
and the role of PI(3,5)P2 signaling in this process.
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Free Michael J. Fox DVD, Video on Parkinson’s Disease
The AAN and the American Brain Foundation present actor and Parkinson’s disease patient
Michael J. Fox hosting Parkinson’s Disease: A Guide for Patients and Families. This new patient
education video is now available free to members and the public, either on DVD or online. The
free DVD can be ordered while supplies last by visiting AAN.com/view/PatientEducationVideos or
calling (800) 879-1960. The video can be viewed online at YouTube.com/AANChannel with other
patient education DVDs produced by the AAN.
Does Your Salary, Profitability Match Your Peers?
The 2013 Neurology Compensation and Productivity Report from the American Academy of Neu-
rology is now available. Compare your salary and practice profitability with your peers in your
community and nationally. Based on 2012 data from hundreds of neurologists and neurology
practice managers, this is the most recent and reliable information for the neurology profession.
Use the Neurology Compensation and Productivity Report to:
• Compare your salary, productivity, and practice characteristics to peers
• Evaluate physician and non-physician provider performance compared to your peers
• Discover fair-market value based on your subspecialty, region, and practice type
• Analyze whether it makes sense to expand your practice
• Identify variances in key metrics for use in practice improvements
Learn more at www.aan.com/view/report.
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